1Lillemoe KD, Yeo CJ, Cameron JL. Pancreatic cancer: state- of-the art care. CA Cancer J Clin, 2000, 50: 241-268.
2Cheng N, Bhowmick NA, Chytil A, et al. Loss of TGF-beta type Ⅱ receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha, MSP and HGF-mediated signaling networks. Oncogene, 2005, 24: 5053-5068.
3Vonlaufen A, Joshi S, Qu C, et al. Pancreatic stellate cells: partners in crime with pancreatic can-cer cells. Cancer Res, 2008. 68:2085-2093.
4Bachem MG, Schunemann M, Ramadani M, et al. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate ceils. Gastroenterology. 2005, 128: 907-921.
5Koide N, Yamada T, Shibata R, et al. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer. Clin Cancer Res, 2006, 12: 2419-2426.
6Gasparini G. The rationale and future potential of angiogenesis inhibitors in neoplasia. Drugs, 1999, 58:17-38.
7Karademir S, Sokmen S, Terzi C, et al. Tumor angiogenesis as a prognostic predictor in pancreatic cancer. J Hepatobiliary Pancreat Surg, 2000, 7:489-495.
8Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2002, 2: 161-174.
9Sawai H, Liu J, Reber HA, et al. Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system. Mol Cancer Res, 2006, 4:159-167.
10Yamanaka Y, Friess H, Kobrin MS, et al. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness, Anticancer Res, 1993, 13: 565-569.
